We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
+74.59%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$637M
AUM Growth
+$160M
(+34%)
Cap. Flow
+$291K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
+$291K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 41.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $372M | 58.34% |
4,373,178
| – | – |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $137M | 21.53% |
2,111,111
| – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $109M | 17.16% |
9,166,667
| – | – |
|
4
Cytokinetics
CYTK
$11.5B
| $19M | 2.97% |
875,656
| – | – |
|
|
VIRX
5
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $16K | ﹤0.01% |
37,005
+33,305
| +900% | +$291K |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC